Positionspapier: Hinweise zur Patienteninformation und-aufklärung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) ∗-Empfehlungen des ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf-und Halschirurgie (DGHNOKHC)-Teil 1: Dupilumab

Translated title of the contribution: Position paper: Suggestions for patient information and education before application of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations of the Medical Association of German Allergologists (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC) - Part 1: Dupilumab

L. Klimek*, A. G. Beule, U. Förster-Ruhrmann, S. Becker, A. Chaker, T. Huppertz, J. Hagemann, T. K. Hoffmann, S. Dazert, T. Deitmer, H. Wrede, W. Schlenter, H. J. Welkoborsky, B. Wollenberg, H. Olze, C. Rudack, A. Sperl, I. Casper, A. Dietz, M. WagenmannT. Zuberbier, K. C. Bergmann, A. Bedbrook, J. Bousquet, C. Bachert

*Corresponding author for this work
Translated title of the contributionPosition paper: Suggestions for patient information and education before application of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations of the Medical Association of German Allergologists (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC) - Part 1: Dupilumab
Original languageGerman
JournalLaryngo- Rhino- Otologie
Volume99
Issue number11
Pages (from-to)761-766
Number of pages6
ISSN0935-8943
DOIs
Publication statusPublished - 01.11.2020

Cite this